The HLA-DQ(α1(*)0102,β1(*)0602) heterodimer may confer susceptibility to multiple sclerosis in the absence of the HLA-DR(α1(*)01,β1(*)1501) heterodimer

Tissue Antigens

Volumn 50, Issue 1, 1997, Pages 15-22

  Spurkland, A ^a,d   Celius, E G ^b   Knutsen, I ^a   Beiske, A ^c   Thorsby, E ^a   Vartdal, F ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^c AKERSHUS UNIVERSITY HOSPITAL   (Norway)

^d UNIVERSITY OF OSLO   (Norway)

Author keywords

HAL DR; HLA DQ; Multiple sclerosis

Indexed keywords

HLA DQ ANTIGEN; HLA DR ANTIGEN;

ALLELE; ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; GENE EXPRESSION; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MULTIPLE SCLEROSIS; NORWAY; PRIORITY JOURNAL;

EID: 0030918147     PISSN: 00012815     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-0039.1997.tb02828.x     Document Type: Article

References (40)

1. Naito S, Namerow N, Mickey MR, Terasaki PI. Multiple sclerosis: association with HL-A3. Tissue Antigens 1972: 2: 1-4.
2. Jersild C, Svejgaard A, Fog T. HL-A antigens and multiple sclerosis. Lancet 1972: 1: 1240-1.
3. Jersild C, Fog T, Hansen GS, Thomsen M, Svejgaard A, Dupont B. Histocompatibility determinants in multiple sclerosis, with special reference to clinical course. Lancet 1973: 2: 1221-5.
4. Tiwaris JL, Terasaki PI. HLA and disease associations. New York: Springer-Verlag, 1985.
5. Thorsby E, Helgesen A, Solheim BG, Vandvik B. HLA antigens in multiple sclerosis. J Neurol Sci 1977: 32: 187-93.
6. Francis DA, Batchelor JR, McDonald WI et al. Multiple sclerosis in north-east Scotland. An association with HLA-DQw1. Brain 1987: 110: 181-96.
7. Spurkland A, Tabira T, Ronningen KS, Vandvik B, Thorsby E, Vartdal F. HLA-DRB1, -DQA1, -DQB1 -DPA1 and -DPB1 genes in Japanese multiple sclerosis patients. Tissue Antigens 1991: 37: 171-3.
8. Olerup O and Hillert J. HLA class II-associated genetic susceptibility in multiple sclerosis: a critical evaluation. Tissue Antigens 1991: 38: 1-15.
9. Serjeantson SW, Gao X, Hawkins BR, Higgins DA, Yu YL. Novel HLA-DR2-related haplotypes in Hong Kong Chinese implicate the DQB1*0602 allele in susceptibility to multiple sclerosis. Eur J Immunogenet 1992: 19: 11-9.
10. Ronningen KS, Spurkland A, Iwe T, Vartdal F, Thorsby E. Distribution of HLA-DRB1, -DQA1 and -DQB1 alleles and DQA1-DQB1 genotypes among Norwegian patients with insulin-dependent diabetes mellitus. Tissue Antigens 1991: 37: 105-11.
11. Schreuder GM, van den Berg-Loonen PM, Verduyn W et al. Increasing complexity of HLA-DR2 as detected by serology and oligonucleotide typing. Hum Immunol 1991: 32: 141-9.
12. Giphart MJ, D'Amaro J, Drabbels JJ et al. Analysis of HLA-DR1 and -DR2 alleles. In: Tsuji K, Aizawa M, and Sasazuki T, ed. HLA 1991. Proceedings of the Eleventh International Histocompatibility Workshop and Conference. Oxford: Oxford Science Publications, 1992: 457-65.
13. Vilches C, de Pablo R, Moreno ME, Solis R, Kreisler M. Characterization of an HLA-DR15 DQ5 haplotype found in the Spanish Caucasoid population. Hum Immunol 1992: 35: 223-9.
14. Mignot E, Hesla PE, Pask S et al. A novel HLA DR17, DQ1 (DQA1-0102/DQB1-0602 positive) predisposing to narcolepsy in Caucasians. Sleep 1993: 16: 764-5.
15. Mignot E, Kimura A, Lattermann A et al. HLA class II studies in non DRB1*1501 patients with narcolepsy-cataplexy. In: Charron D and Fauchet R, ed. HLA 1996. Proceedings of the 12th International Histocompatibility Workshop and Conference: Genetic Diversity of HLA: Functional and Medical Implications. Paris: EDK Press (in press).
16. Roushdy J, Santoso S, Kalb R, Meier-Ewert K, Albert ED, Mueller-Eckhardt G. A deletion in the second exon of an HLA-DRB1 allele found in a DR2-negative narcolepsy patient. Hum Immunol 1993: 37: 1-6.
17. Fernandez-Viña MA, Tiercy J-M, Tonai R, Katovich-Hurley C, Tsai J, Stastny P. DNA typing of DRB1 and DRB3 DR52-related specificities. In: Tsuji K, Aizawa M, Sasazuki T, ed. HLA 1991. Proceedings of the Eleventh International Histocompatibility Workshop and Conference. Vol. 1. Oxford: Oxford Science Publications, 1992: 471-7.
18. Mignot E, Lin X, Arrigoni J et al. DQB1*0602 and DQA1*0102 (DQ1) are better markers than DR2 for narcolepsy in Caucasian and black Americans. Sleep 1994: 17 (suppl): S60-7.
19. Poser CM, Paty DW, Scheinberg L et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983: 13: 227-31.
20. Vartdal F, Sollid LM, Vandvik B, Markussen G, Thorsby E. Patients with multiple sclerosis carry DQB1 genes which encode shared polymorphic amino acid sequences. Hum Immunol 1989: 25: 103-10.
21. Spurkland A, Ingvarsson G, Falk ES, Knutsen I, Sollid LM, Thorsby E. Dermatitis herpetiformis and celiac disease are both primarily associated with the HLA-DQ(α1*0501,β1*02) or the HLA-DQ(α1*03,β1*0302) heterodimers. Tissue Antigens 1997: 49: 29-34.
22. Kimura A, Sasazuki T. Eleventh International Histocompatibility Workshop reference protocol for the HLA DNA-typing technique. In: Tsuji K, Aizawa M, Sasazuki T, ed. HLA 1991. Proceedings of the Eleventh International Histocompatibility Workshop and Conference. Vol. 1. Oxford: Oxford Science Publications, 1992: 397-419.
23. Spurkland A, Knutsen I, Markussen G, Vartdal F, Egeland T, Thorsby E. HLA matching of unrelated bone marrow transplant pairs: direct sequencing of in vitro amplified HLA-DRB1 and -DQB1 genes using magnetic beads as solid support. Tissue Antigens 1993: 41: 155-64.
24. Bodmer JG, Marsh SG, Albert ED et al. Nomenclature for factors of the HLA system, 1994. Hum Immunol 1994: 41: 1-20.
25. Todd JA, Bell JI, McDevitt HO. HLA-DQ beta gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus. Nature 1987: 329: 599-604.
26. Horn GT, Bugawan TL, Long CM, Erlich HA. Allelic sequence variation of the HLA-DQ loci: relationship to serology and to insulin-dependent diabetes susceptibility. Proc Natl Acad Sci U S A 1988: 85: 6012-6.
27. Tsuji K, Aizawa M, Sasazuki T, ed. HLA 1991. Proceedings of the Eleventh International Histocompatibility Workshop and Conference. Oxford: Oxford Science Publications, 1992.
28. Tiwaris JL, Terasaki PI. The data and the statistical methods. In: HLA and disease associations. New York: Springer Verlag, 1985: 18-27.
29. Olerup O, Zetterquist H. HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: an alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation. Tissue Antigens 1992: 39: 225-35.
30. Johansen B, Jensen T, Thorpe CJ, Vartdal F, Thorsby E, Sollid LM. Both α- and β-chain polymorphisms determine the specificity of the coeliac disease associated HLA-DQ2 molecule with β-chain residues being most influential. Immunogenetics 1996: 45: 142-50.
31. Ronningen KS, Spurkland A, Tait BD et al. HLA class II associations in insulin-dependent diabetes mellitus among Blacks, Caucasoids and Japanese. In: Tsuji K, Aizawa M, Sasazuki T, ed. HLA 1991. Proceedings of the 11th International Histocompatibility Workshop and Conference. Oxford: Oxford University Press, 1992: 713-22.
32. Zeliszewski D, Tiercy JM, Boitard C et al. Extensive study of DRB, DQA, and DQB gene polymorphism in 23 DR2-positive, insulin-dependent diabetes mellitus patients. Hum Immunol 1992: 33: 140-7.
33. Kurtzke JF. Epidemiologic contributions to multiple sclerosis: an overview. Neurology 1980: 30: 61-79.
34. Mehra NK, Bouwens AG, Naipal A et al. Asian Indian HLA-DR2-, DR4-, and DR52-related DR-DQ genotypes analyzed by polymerase chain reaction based nonradioactive oligonucleotide typing. Unique haplotypes and a novel DR4 subtype. Hum Immunol 1994: 39: 202-10.
35. Reijonen H, Ilonen J, Akerblom HK, Knip M, Dosch HM. Multi-locus analysis of HLA class II genes in DR2-positive IDDM haplotypes in Finland. The "Childhood Diabetes in Finland" (DiMe) Study Group. Tissue Antigens 1994: 43: 1-6.
36. Sanjeevi CB, Lybrand TP, Landin-Olsson M et al. Analysis of antibody markers, DRB1, DRB5, DQA1 and DQB1 genes and modeling of DR2 molecules in DR2-positive patients with insulin-dependent diabetes mellitus. Tissue Antigens 1994: 44: 110-9.
37. Undlien DE, Friede T, Rammensee HG et al. HLA encoded genetic predisposition in insulin-dependent diabetes mellitus (IDDM). DR4 subtypes may be associated with different degrees of protection. Diabetes (in press).
38. Benmamar D, Martinez-Laso J, Varela P, Bekhoucha F, Morales P, Arnaiz-Villena A. Evolutionary relationships of HLA-DR8 alleles and description of a new subtype (DRB1*0806) in the Algerian population. Hum Immunol 1993: 36: 172-8.
39. Bugawan TL, Chang JD, Klitz W, Erlich HA. PCR/oligonucleotide probe typing of HLA class II alleles in a Filipino population reveals an unusual distribution of HLA haplotypes. Am J Hum Genet 1994: 54: 331-40.
40. Allen M, Sandberg-Wollheim M, Sjögren K, Erlich HA, Petterson U, Gyllensten U. Association of susceptibility to multiple sclerosis in Sweden with HLA class II DRB1 and DQB1 alleles. Hum Immunol 1994: 39: 41-8.